NewKerala.com

HPV Vaccine's Hidden Benefit: How It Shields Women From More Than Cervical Cancer

The HPV vaccine offers protection beyond just cervical cancer. A large-scale study found it significantly reduces the risk of precancerous lesions in the vulva and vagina. This benefit is most powerful when girls receive the vaccine at a young age, between 10 and 16. The research highlights the vaccine's critical role in comprehensive women's health.

Key Points: HPV Vaccine Prevents Vulvar Vaginal Precancerous Lesions Study Finds

  • Study shows a 37% lower incidence of high-grade vulvovaginal lesions in vaccinated women
  • Risk reduction jumps to 57% for women vaccinated between ages 10 and 16
  • Research analyzed nearly 780,000 women in Sweden over a 16-year period
  • Early vaccination is key, likely due to lower prior exposure to the HPV virus
2 min read

HPV vaccine can help prevent precancerous lesions in girls, women

A major Swedish study reveals the HPV vaccine significantly reduces the risk of high-grade vulvovaginal precancerous lesions, especially when given early.

"The findings emphasise the critical role of HPV vaccination initiated at an early age. - Researchers, Karolinska Institutet"

New Delhi, Dec 20

The Human papillomavirus (HPV) vaccine, known for preventing cervical cancer, can also help safeguard against precancerous lesions of the vulva and vagina in girls and women, according to a study.

The study, published in the journal JAMA Oncology, showed that women who received at least 1 dose of the quadrivalent HPV vaccine had a 37 per cent lower incidence of high-grade vulvovaginal lesions than those unvaccinated.

The incidence reduction of high-grade vulvovaginal lesions was statistically significant among women vaccinated at 10 to 16 years, as their rate of vaginal or vulvar precancers was 57 per cent lower compared to unvaccinated women.

“The findings emphasise the critical role of HPV vaccination initiated at an early age. The enhanced risk reduction in younger women may be attributable to the reduced probability of prior HPV exposure before vaccination,” said researchers from the Karolinska Institutet in Sweden.

The team conducted a cohort study of 7,78,943 women, born from 1985 to 1998 and living in Sweden from 2006 to 2022.

During the follow-up, 98 cases of high-grade vulvovaginal lesions were found in vaccinated women, and 547 cases were found in unvaccinated women.

Compared with unvaccinated women, the fully adjusted incidence rate ratio of high-grade vulvovaginal lesions was 0.63 in vaccinated women.

Vulvar and vaginal lesions are diverse skin changes (bumps, sores, cysts, discoloration) around the genitals, ranging from benign (infections, cysts, skin conditions like lichen sclerosus) to precancerous (VIN) or cancerous. These often cause itching, pain, burning, or discharge.

Finding vulvar and vaginal lesions at the precancerous stage -- before they transform into life-threatening cancer -- is important because early detection increases the odds of being cured.

HPV is the most common sexually transmitted infection globally and is responsible for more than 690,000 new cancer cases annually. It is the primary cause of cervical cancer, along with several other genital and head and neck cancers in both women and men.

A recent study showed that the HPV vaccine may not only prevent cervical cancer, but also provides significant herd immunity effects, offering protection even to young women who were not vaccinated.

- IANS

Share this article:

Reader Comments

R
Rohit P
Great to see solid data backing up the vaccine's benefits beyond just cervical cancer. Prevention is always better than cure. The government should seriously consider including this in the universal immunization program, even if it's a phased rollout. The long-term healthcare savings would be massive.
A
Anjali F
While the science is clear, the cost is a major barrier for many families in India. The vaccine is still quite expensive in the private sector. Hope the prices come down or more state governments start free programs like some have already done.
D
David E
The herd immunity point at the end is crucial. Protecting one group helps protect the whole community. This is a powerful public health tool. More parents need to have open, informed conversations about this with their doctors, beyond the social stigma.
K
Karthik V
Respectfully, I feel the article and most discussions focus only on girls. HPV causes cancers in men too (throat, penile). The vaccine is recommended for boys as well in many countries. We need a more balanced awareness campaign that includes everyone who can benefit.
S
Sneha F
Early detection is mentioned, but how many women in smaller towns and villages have access to regular screenings for these precancerous lesions? The vaccine is a proactive shield. Kudos to the researchers for this large-scale study. Hope our policymakers are paying attention.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50